The company, which employs 175 people in Ireland, said the investment has allowed it to increase
production of cancer and rare disease medicines by 10 per cent from its Blanchardstown manufacturing facility.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: